Genus Prime Infra Limited
BSE: GENUSPRIME · Commodity Chemicals · sector
Key numbers
Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 70 companies in Commodity Chemicals (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹1 cr vs borrowings ₹41 cr (FY26): borrowings are higher by ₹40 cr.
- Operating profit covered interest 8.4x in the last 12 months.
- Net loss in 1 of the last 6 quarters.
- Other income was 74% of net profit in the last 12 months.
- No dividend in the last 5 financial years.
- Price ₹18.08 on 2026-10-26: -69.8% from the 52-week high, +4.3% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Quarterly results
| ₹ cr | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 1 | 1 | 1 | 1 | 1 |
| EBITDA | -0 | 0 | 1 | 1 | 2 | 1 |
| OPM % | -100.0% | 56.5% | 75.0% | 67.5% | 131.9% | 84.1% |
| Other income | 0 | 0 | 0 | 0 | 3 | 1 |
| Net profit | -0 | 0 | 0 | 0 | 4 | 2 |
| EPS (₹) | 0.02 | 0.08 | 0.34 | 0.11 | 3.06 | 0.21 |
| Revenue YoY | +5,700.0% | +103.2% | ||||
| Profit YoY | – | +4,933.3% |
Consolidated figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 4 | 5 |
| EBITDA | -0 | -0 | -0 | -0 | 4 | 4 |
| Net profit | -0 | -0 | -0 | -0 | 5 | 6 |
| EPS (₹) | -0.03 | -0.01 | -0.01 | 0.02 | 3.59 | 3.72 |
| Revenue growth | -5.0% | +5.3% | +10.0% | +1,827.3% | – | |
| Profit growth | – | – | – | – | – | |
| Dividend / share (₹) | – | – | – | – | – |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | +181.6% | – | – |
| Net profit | – | – | – |
| EPS | – | – | – |
| Share price | – | -13.9% (2y) | -9.3% |
Balance sheet
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Shareholders' equity | 46 | 211 |
| Borrowings | 22 | 41 |
| Cash & equivalents | 0 | 1 |
| Total assets | 67 | 300 |
| Fixed assets | 0 | 26 |
| Capital work in progress | – | 2 |
| Investments | 61 | 0 |
| Receivables | 0 | 6 |
| Inventory | 0 | 1 |
| Payables | 0 | 4 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Cash from operations | 0 | 1 |
| Cash from investing | 0 | 1 |
| Cash from financing | 0 | -1 |
| Capex | 0 | 0 |
| Free cash flow | 0 | 1 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY25 | FY26 |
|---|---|---|
| ROE % | -0.1% | 2.2% |
| ROCE % | -0.1% | 2.4% |
| Debtor days | 0 | 560 |
| Inventory days | 0 | 68 |
| Payable days | 0 | 385 |
| Cash conversion cycle (days) | 0 | 243 |
| Working capital days | 196 | 987 |
Peers in Commodity Chemicals
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| SRF | ₹69,362 cr | 30.4x | 4.5x | 16.0% | 15.2% | 21.4% | +373.5% | 0.38% |
| TATACHEM | ₹15,184 cr | – | 0.7x | -10.1% | -4.2% | -1.6% | -4.6% | 1.84% |
| DEEPAKFERT | ₹14,422 cr | 14.7x | 2.1x | 15.1% | 13.6% | 16.7% | +0.6% | 0.89% |
| GNFC | ₹7,634 cr | 7.4x | 0.8x | 11.7% | 15.2% | 14.8% | -8.7% | 3.41% |
| TANFACIND | ₹4,989 cr | 66.3x | 13.4x | 19.7% | 20.5% | 15.5% | +23.8% | – |
| GUJALKALI | ₹4,043 cr | 60.9x | 0.8x | 1.2% | 3.6% | 11.3% | -1.2% | 2.88% |
| GRAUWEIL | ₹3,537 cr | 22.1x | 3.3x | 15.9% | 19.6% | 15.3% | +6.8% | 0.64% |
| GHCL | ₹3,486 cr | 6.7x | 1.0x | 14.9% | 19.9% | 24.8% | -12.3% | 3.29% |
| JGCHEM | ₹2,190 cr | 29.1x | 4.1x | 15.1% | 19.8% | 8.9% | – | 0.18% |
| GENUSPRIME | ₹24 cr | 4.9x | 0.1x | 4.7% | 3.0% | 89.1% | +181.6% | – |
Documents
Links go to the original files on the exchange website.
About the company
| Sector | Commodities |
| Industry | Commodity Chemicals |
| Sub-industry | Commodity Chemicals |
| Symbol | GENUSPRIME |
| BSE code | 532425 |
| ISIN | INE256D01014 |
| Face value | ₹2.0 |
| Incorporated | – |
| Website | – |
| Plants (India / abroad) | – |
Data built 2026-10-23 from BSE company filings (inline XBRL: Integrated Filing - Finance) + BSE results summary for earlier years; price = BSE close 2026-10-26.